202
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Risk Factors and Prognostic Implications of New-Onset Paroxysmal Atrial Fibrillation in Patients Hospitalized with Intracerebral Hemorrhage

ORCID Icon, , , , , & show all
Pages 1973-1981 | Received 21 Mar 2023, Accepted 12 May 2023, Published online: 23 May 2023

References

  • Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. doi:10.1093/eurheartj/ehaa612
  • Thijs VN, Brachmann J, Morillo CA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: results from crystal af. Neurology. 2016;86(3):261–269. doi:10.1212/WNL.0000000000002282
  • Gladstone DJ, Dorian P, Spring M, et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the embrace trial. Stroke. 2015;46(4):936–941. doi:10.1161/STROKEAHA.115.008714
  • Israel C, Kitsiou A, Kalyani M, et al. Detection of atrial fibrillation in patients with embolic stroke of undetermined source by prolonged monitoring with implantable loop recorders. Thromb Haemost. 2017;117(10):1962–1969. doi:10.1160/TH17-02-0072
  • Bisson A, Bodin A, Clementy N, Babuty D, Lip GYH, Fauchier L. Prediction of incident atrial fibrillation according to gender in patients with ischemic stroke from a nationwide cohort. Am J Cardiol. 2018;121:437–444. doi:10.1016/j.amjcard.2017.11.016
  • Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009;373:739–745. doi:10.1016/S0140-6736(09)60443-8
  • Friberg L, Rosenqvist M, Lindgren A, Terént A, Norrving B, Asplund K. High prevalence of atrial fibrillation among patients with ischemic stroke. Stroke. 2014;45:2599–2605. doi:10.1161/STROKEAHA.114.006070
  • Putaala J, Lehto M, Meretoja A, et al. In-hospital cardiac complications after intracerebral hemorrhage. Int J Stroke. 2014;9:741–746. doi:10.1111/ijs.12180
  • Horstmann S, Rizos T, Jenetzky E, Gumbinger C, Hacke W, Veltkamp R. Prevalence of atrial fibrillation in intracerebral hemorrhage. Eur J Neurol. 2014;21(4):570–576. doi:10.1111/ene.12215
  • Prats-Sanchez L, Guisado-Alonso D, Painous C, et al. Insular damage, new-onset atrial fibrillation and outcome after acute intracerebral hemorrhage. Eur J Neurol. 2018;25:491–496. doi:10.1111/ene.13522
  • Henninger N, Goddeau RP Jr, Karmarkar A, Helenius J, McManus DD. Atrial fibrillation is associated with a worse 90-day outcome than other cardioembolic stroke subtypes. Stroke. 2016;47(6):1486–1492. doi:10.1161/STROKEAHA.116.012865
  • Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021;107(7):535–541. doi:10.1136/heartjnl-2020-317915
  • Masini G, Graham FJ, Pellicori P, et al. Criteria for iron deficiency in patients with heart failure. J Am Coll Cardiol. 2022;79:341–351. doi:10.1016/j.jacc.2021.11.039
  • Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European society of cardiology (esc). Eur Heart J. 2010;31(19):2369–2429. doi:10.1093/eurheartj/ehq278
  • Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Aspects study group. Alberta stroke programme early ct score. Lancet. 2000;355(9216):1670–1674. doi:10.1016/S0140-6736(00)02237-6
  • Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304–1305. doi:10.1161/01.STR.27.8.1304
  • Hanley DF, Lane K, McBee N, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled clear iii trial. Lancet. 2017;389(10069):603–611. doi:10.1016/S0140-6736(16)32410-2
  • Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375(11):1033–1043. doi:10.1056/NEJMoa1603460
  • Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. doi:10.1056/NEJMoa1313600
  • Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–2477. doi:10.1056/NEJMoa1311376
  • Haeusler KG, Kirchhof P, Kunze C, et al. Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (mondafis): a randomised, open-label, multicentre study. Lancet Neurol. 2021;20(6):426–436. doi:10.1016/S1474-4422(21)00067-3
  • Wachter R, Gröschel K, Gelbrich G, et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (find-af randomised): an open-label randomised controlled trial. Lancet Neurol. 2017;16(4):282–290. doi:10.1016/S1474-4422(17)30002-9
  • Bahit MC, Sacco RL, Easton JD, et al. Predictors of atrial fibrillation development in patients with embolic stroke of undetermined source: an analysis of the re-spect esus trial. Circulation. 2021;144(22):1738–1746. doi:10.1161/CIRCULATIONAHA.121.055176
  • Kim BS, Chun KJ, Hwang JK, et al. Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices. Medicine. 2016;95(28):e4181. doi:10.1097/MD.0000000000004181
  • Fonseca AC, Brito D, Pinho e Melo T, et al. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients. Int J Stroke. 2014;9:419–425. doi:10.1111/ijs.12126
  • Wachter R, Lahno R, Haase B, et al. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--The find-af study. PLoS One. 2012;7:e34351. doi:10.1371/journal.pone.0034351
  • Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230–243. doi:10.1038/nrcardio.2015.2
  • Keep RF, Xiang J, Ennis SR, et al. Blood-brain barrier function in intracerebral hemorrhage. Acta Neurochir Suppl. 2008;105:73–77.
  • Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol. 2010;92(4):463–477. doi:10.1016/j.pneurobio.2010.08.001
  • Wang J, Doré S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007;27(5):894–908. doi:10.1038/sj.jcbfm.9600403
  • Keep RF, Hua Y, Xi G. Intracerebral haemorrhage: mechanisms of injury and therapeutic targets. Lancet Neurol. 2012;11(8):720–731. doi:10.1016/S1474-4422(12)70104-7
  • Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T. Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med. 2008;36(11):3074–3079. doi:10.1097/CCM.0b013e31818b306d
  • Sykora M, Steiner T, Poli S, Rocco A, Turcani P, Diedler J. Autonomic effects of intraventricular extension in intracerebral hemorrhage. Neurocrit Care. 2012;16(1):102–108. doi:10.1007/s12028-011-9637-1
  • Coumel P, Attuel P, Lavallée J, Flammang D, Leclercq JF, Slama R. [The atrial arrhythmia syndrome of vagal origin]. Arch Mal Coeur Vaiss. 1978;71(6):645–656. French.
  • Amar D, Zhang H, Miodownik S, Kadish AH. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol. 2003;42:1262–1268. doi:10.1016/S0735-1097(03)00955-0
  • Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105(23):2753–2759. doi:10.1161/01.CIR.0000018443.44005.D8
  • Tomita T, Takei M, Saikawa Y, et al. Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol. 2003;14(6):559–564. doi:10.1046/j.1540-8167.2003.02462.x
  • Tan AY, Zhou S, Ogawa M, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation. 2008;118(9):916–925. doi:10.1161/CIRCULATIONAHA.108.776203
  • Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30(4):1039–1045. doi:10.1016/S0735-1097(97)00254-4
  • O’Neill PG, Puleo PR, Bolli R, Rokey R. Return of atrial mechanical function following electrical conversion of atrial dysrhythmias. Am Heart J. 1990;120(2):353–359. doi:10.1016/0002-8703(90)90079-D
  • Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–993. doi:10.1161/01.STR.24.7.987
  • Fogelholm R, Murros K, Rissanen A, Avikainen S. Long term survival after primary intracerebral haemorrhage: a retrospective population based study. J Neurol Neurosurg Psychiatry. 2005;76:1534–1538. doi:10.1136/jnnp.2004.055145
  • Lindner A, Kofler M, Rass V, et al. Early predictors for infectious complications in patients with spontaneous intracerebral hemorrhage and their impact on outcome. Front Neurol. 2019;10:817. doi:10.3389/fneur.2019.00817